# A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of RO7268489 as Add-on Therapy to Ocrelizumab, in Participants With Progressive Forms of Multiple Sclerosis (MS)

> clinical trial · VERIFIED · 2026-08-17

Status: RECRUITING · Sponsor: Hoffmann-La Roche · Condition: Progressive Multiple Sclerosis

- Company: Hoffmann-La Roche
- Sector: therapeutics
- Primary source: https://clinicaltrials.gov/study/NCT07282574

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.